Zobrazeno 1 - 10
of 28
pro vyhledávání: '"I S Davidenko"'
Publikováno v:
Современная онкология, Vol 16, Iss 1, Pp 26-29 (2014)
Ovarian cancer is one of the most widely spread among women malignant tumors. Despite high sensitivity to anti-cancer chemotherapy (responses are awaited from more than 80% of women, receiving standard therapy with platinum and paclitaxel) recurrence
Externí odkaz:
https://doaj.org/article/432cede3f9974e759cff15d1fc6164e0
Autor:
I V Poddubnaya, S A Bichurina, E V Bobrovskaya, L Yu Vladimirova, S S Gordeev, I S Davidenko, S A Emelyanov, O V Zharkova, I A Koroleva, S Yu Krasilnikova, S Ch Maikoparova, T A Malysheva, A A Modestov, A N Morozov, V A Petrukhnenko, I D Sivunova, G B Stachenko, E A Strygina, E Kh Tlish, P S Feoktistova, A S Chichkanova, N Z Sherman
Publikováno v:
Современная онкология, Vol 16, Iss 1, Pp 36-41 (2014)
The article reports the preliminary results of the observation program studying the application of bevacizumab in patients with metastatic colorectal cancer (mCRC) in daily clinical practice in Russian.Methods. The observation program is based on the
Externí odkaz:
https://doaj.org/article/07a5d4d5a62e490ba3b4a176e9c1c952
Autor:
I V Poddubnaya, E V Bobrovskaya, L Yu Vladimirova, S S Gordeev, I S Davidenko, S A Emelyanov, O V Zharkova, I A Koroleva, S Yu Krasilnikova, S Ch Maikoparova, T A Malysheva, A A Modestov, A N Morozov, G B Stachenko, E A Strygina, E Kh Tlish, P S Feoktistova, A S Chichkanova, N Z Sherman
Publikováno v:
Современная онкология, Vol 15, Iss 1, Pp 5-9 (2013)
Objective: to estimate the average duration of therapy with Avastin (bevacizumab) in patients with metastatic colorectal cancer (mCRC) in the daily clinical practice of cancer care facilities in Russia. Methods. The observational program is being imp
Externí odkaz:
https://doaj.org/article/72eb69854ce44bde8dd9aff81282564d
Autor:
K S Elizbaryan, M V Kazantseva, I S Davidenko, S N Potemin, D V Andreev, O P Burdik, A I Stukan'
Publikováno v:
Современная онкология, Vol 14, Iss 3, Pp 77-80 (2012)
Externí odkaz:
https://doaj.org/article/bb70ffead828452c9201944def4aa160
Autor:
I V Poddubnaya, M R Lichinitser, S A Tyulyandin, V A Gorbunova, V V Ptushkin, M A Abramov, N S Besova, L V Bolotina, I S Bulavina, O A Gladkov, I S Davidenko, L G Zhukova, I A Koroleva, V O Korolenko, G M Manikhas, A V Snegovoy, Yu I Tyukalov, R Sh Khasanov, L N Shigapova
Publikováno v:
Современная онкология, Vol 13, Iss 2, Pp 50-56 (2011)
Externí odkaz:
https://doaj.org/article/6988344d7af547529dcd0ffe010d684e
Publikováno v:
Современная онкология, Vol 15, Iss 4, Pp 47-49 (2013)
High incidence of ovarian cancer, the identification of the majority of patients in late stages (65–70% – III–IV stage), short-term survival until relapse, repeated following surgeries and chemotherapy determine the necessity of search for effe
Externí odkaz:
https://doaj.org/article/b39f0015238d4ef88364ba1afb629452
Publikováno v:
Современная онкология, Vol 14, Iss 4, Pp 53-55 (2012)
Externí odkaz:
https://doaj.org/article/4614392f27fa41d69517aa4809cbaa09
Publikováno v:
Современная онкология, Vol 3, Iss 3, Pp 114-117 (2001)
В настоящее время в онкологии, как и в других отраслях медицины, врачи должны заботиться не только об увеличении продолжительности жизн
Externí odkaz:
https://doaj.org/article/f2c53043aace4508913452983a86edc1
Autor:
M V Kazantseva, I S Davidenko
Publikováno v:
Современная онкология, Vol 8, Iss 3, Pp 62-64 (2006)
Одним из частых симптомов, сопровождающих течение злокачественных новообразований, является анемия. С момента диагностирования злокач
Externí odkaz:
https://doaj.org/article/b90b3b690d914db4966e8b4a845c65ed
Publikováno v:
Современная онкология, Vol 7, Iss 2, Pp 84-86 (2005)
Выбор режима химиотерапии второй линии метастатического рака молочной железы (РМЖ) представляет собой сложную проблему. Арсенал комбин
Externí odkaz:
https://doaj.org/article/bfe3bfc3cf8046b9b4db11acf9e2927b